Kirsten Gillibrand (D-NY)
PFAS Accountability Act of 2025
A Democratic bill with no cosponsors
Last activity — Read twice and referred to the Committee on Environment and Public Works.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The PFAS Accountability Act of 2025 seeks to amend the Toxic Substances Control Act. It aims to create a Federal cause of action for people significantly exposed to per- and polyfluoroalkyl substances (PFAS). The bill establishes a medical monitoring remedy to help address the harm caused by exposure. It intends to provide accountability for irresponsible PFAS manufacturing and use. Additionally, the act seeks to provide incentives for industry to fund research into the safety of these substances.
Yes· 3 of 8
- Scored +7
Does this better protect air, water and wildlife?
The bill increases accountability for the irresponsible discharge and manufacturing of PFAS substances.
- Scored +6
Does this give people more protection from unfair business practices?
The bill creates a federal cause of action for individuals exposed to harmful PFAS substances.
- Scored +5
Does this put more money into scientific research?
The bill provides incentives for industry to fund research and allows courts to order additional scientific studies on PFAS safety.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
New Legal Recourse: The bill codifies a Federal cause of action, allowing individuals who are significantly exposed to PFAS to bring claims in district court (Section 3 and Section 4(b)).
-
Medical Monitoring: The act provides a remedy where courts may award medical monitoring to individuals or classes. This helps cover the costs of periodic diagnostic medical examinations that are necessary due to increased disease risks from exposure (Section 3 and Section 4(c)(1)).
-
Shifting Financial Burdens: The bill aims to shift the costs of medical monitoring from the affected individuals to the parties responsible for the exposure (Section 3).
-
Presumption of Exposure: The bill establishes a presumption that an individual was significantly exposed if they can demonstrate the defendant's involvement in the manufacturing process and a release of PFAS into an area of exposure for at least one year (Section 4(c)(2)(A)(i)).
-
Scientific Data Collection: Courts are given the authority to order new or additional epidemiological, toxicological, or other studies to provide reliable data regarding the health risks of PFAS (Section 4(c)(4)(B)).
Potential Negative Impacts for People
-
Burden of Proof for Disease Risk: While the bill allows for a lower standard of scientific proof if data is insufficient, the requirement still exists to show an increased risk of developing a disease associated with exposure (Section 4(c)(4)(A)).
-
Defendant Ability to Rebut: A defendant can challenge the presumption of significant exposure by providing independent testing results that suggest the PFAS levels were not sufficient to qualify as significant exposure (Section 4(c)(3)(A)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Environment Energy And Infrastructure
- Does this better protect air, water and wildlife? — The bill increases accountability for the irresponsible discharge and manufacturing of PFAS substances.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — The bill helps offset the medical costs associated with chronic disease risks that could otherwise burden low-income families. Would people with disabilities be better off under this? — By funding medical monitoring, the bill may assist in the early detection of health issues that impact long-term wellbeing.
- Economy And Finance
- Does this give people more protection from unfair business practices? — The bill creates a federal cause of action for individuals exposed to harmful PFAS substances.
- Education And Technology
- Does this put more money into scientific research? — The bill provides incentives for industry to fund research and allows courts to order additional scientific studies on PFAS safety.
- Healthcare
- Does this make health care easier to get in general? — The bill establishes a medical monitoring remedy to help cover the costs of necessary diagnostic examinations for those exposed to PFAS.
- Governance And Ideology
- Does this protect the right to fair treatment by the courts? — The bill codifies specific legal presumptions and standards of proof to assist individuals in seeking legal recourse.
- Social Issues And Justice
- Is this likely to lift people out of poverty? — By shifting the costs of medical monitoring from individuals to responsible parties, the bill reduces potential medical debt for exposed persons.
- 12/11/2025
- Read twice and referred to the Committee on Environment and Public Works.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.